Interview with Günter Cseh, General Manager, Meda Pharma Austria
What have been the most significant developments as a result of the acquisition of Viatris by Meda Pharma in 2005? At that time Viatris was a small company, and there…
Address: Guglgasse 15/II. Stock, 1110 Vienna,Austria
Tel: +43 + (1) 86390-0
Web: http://www.meda.at/content/home/index.php
Meda is a leading specialty pharmaceutical company in Europe that offers cost-oriented medicine and the medical need. With offices in 26 countries Meda covers almost the whole of Europe. In other world markets, the pharmaceuticals are marketed by Meda and other representatives of pharmaceutical companies and sold.
Meda focuses on the treatment areas asthma & allergies, cardiovascular disease, pain and inflammation, gastroenterology and dermatology & infections.
Meda Pharma GmbH with its headquarters in Vienna (see photo) is a subsidiary of Meda AB., Sweden. Meda Pharma Austria looks back on a long company history, what with the PANCHEMIE HOMBURG found its founding. Subsequently developed into ASTA MEDICA Arzneimittel GmbH, which was renamed in 2002 in VIATRIS Pharma GmbH and since October 2005, owned by the Swedish pharmaceutical company Meda is.
Meda Pharma GmbH Austria continues its focus on products for the therapy and treatment of respiratory diseases (Novolizer ®, Allergodil ®), pain (Adamon ®) for the prevention and treatment of osteoporosis (Maxi-Kalz ®), treatment of cardiovascular disease (Magnosolv ®, Aquaphoril ®) and a specific complication of diabetes mellitus (Thioctacid ®), as well as therapeutic agents for use in the Department of Gynecology (Cyklokapron ® Ftbl., Estrogel ®, Utrogestan ®, Parlodel ®). Another therapeutic area of Meda Pharma, the treatment of skin diseases, such as the actinic keratoses, basal cell carcinomas or genital warts (Aldara ®). The innovative nutritional supplements Longeva ® completes the product range.
Furthermore, there are good pharmacy products such as Ce-soda ®, Histaxin ®, and Kamillosan Travelgum ® and the dietary supplement Osteo-Active ® and Magnofit ® – pellets in the product portfolio of Meda Austria.
What have been the most significant developments as a result of the acquisition of Viatris by Meda Pharma in 2005? At that time Viatris was a small company, and there…
Barbara Fritsche-Surchat, general manager of Servier Austria, a leading innovative French company looking to bolster its global oncology presence, provides an in-depth analysis of the balancing act between pricing and…
Martin Spatz, country manager of QuintilesIMS Austria, the global leader in healthcare market research, discusses the diverse range of services they provide to the two separate entities of the of…
Rudolf Wessely, CEO and founder of Gynial, the Austrian leader in oral contraceptives, elaborates on the company’s incredibly fast market penetration since 2007 and explains his expertise in the contraceptive…
Bernhard Wittmann, managing director of Sigmapharm and MoNo, discusses the company’s product portfolio and the diverse tailored services for their partners. Furthermore, he provides an in-depth look into MoNo’s new…
Martin Tiani, CEO of Tiani Spirit, the global leader in Integrating the Healthcare Enterprise (IHE), discusses the importance of interoperability within electronic health information exchange (HIE) and the challenges e-health faces, especially…
Dr. Dietmar Katinger, CEO of Polymun, an Austrian R&D and contract manufacturing company, discusses the challenges CMO companies face within the Austrian market and increasing industry regulations. He also provides…
Like a family recipe that has been refined and perfected over countless generations, Austria has developed a reputation as the quintessential clinical trials destination; a perfect combination of world-class academia,…
Dr. Kurt Zatloukal, national node director of the Bio-Banking and Bio-Molecular Resources Research Infrastructure of Austria (BBMRI Austria), discusses the challenges of collaboration between the private and academic pharmaceutical sectors…
Dr. Daniel Wallerstorfer, CEO and founder of Novogenia, a vibrant Austrian genetics company, discusses founding his own company and the innovative services Novogenia provides to ensure genetics are a staple…
Günther Aschenbrenner, managing director of Théa Austria, a specialist French ophthalmology company, discusses the development of the company’s Austrian office since 2011 and how a strong portfolio acquired by Théa…
Daniela Homan, executive director of AmCham Austria, the representative and advocating voice of US companies in Austria, provides an in-depth analysis of the strategies being employed by the chamber and…
Karl Peter Schwarz, general manager of the Austrian affiliate of LEO Pharma, an ambitious Danish company leading the way in innovative dermatology treatments, provides an in-depth look into how global…
See our Cookie Privacy Policy Here